Literal source text
Lobbying issues and bill citations
HCR · Health Issues
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Literal federal measure citations: H.R. 7779, H.Res.1318, S.Res.752
ENV · Environment/Superfund
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Literal federal measure citations: H.R. 7779, H.Res.1318, S.Res.752
MED · Medical/Disease Research/Clinical Labs
Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.
Literal federal measure citations: H.R. 7779, H.Res.1318, S.Res.752